Initial Results of PX-171-004, An Open-Label, Single-Arm, Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed Myeloma (MM)

被引：0

作者：

Vu, Ravi ^{[1
]}

Wang, Michael ^{[2
]}

Orlowski, Robert ^{[2
]}

Stewart, A. Keith ^{[3
]}

Jagannath, Sundar ^{[4
]}

Kukreti, Vishal ^{[5
]}

Taylor, Jessica ^{[6
]}

Fuhrman, Diana ^{[6
]}

Cruickshank, Scott ^{[6
]}

Schwartz, Richard ^{[6
]}

Kunkel, Lori ^{[6
]}

Siegel, David ^{[7
]}

机构：

[1] Washington Univ, Sch Med, St Louis, MO USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Mayo Clin, Scottsdale, AZ USA

[4] St Vincents Comp Canc Ctr, New York, NY USA

[5] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[6] Proteolix Inc, Clin Operat, San Francisco, CA USA

[7] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[8] MMRC, Norwalk, CT USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：320 / 320

页数：1